Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Justine Lequesne is a pioneering surgeon whose work sits at the critical intersection of robotic surgery and oncology, with a particular focus on improving outcomes for complex patient populations. Her primary research areas include transoral robotic surgery (TORS) for head and neck cancers and minimally invasive surgical management of gynecologic malignancies. Dr. Lequesne’s most cited work, "Chirurgie robotique du cancer de l’endomètre chez la patiente obèse" (2018), established her as a leading voice in adapting robotic techniques for obese patients with endometrial cancer, addressing a significant clinical challenge where traditional surgery carries higher risks. Her most impactful contribution to date is the RoboCUP trial protocol (2025), a randomized phase 2 study comparing TORS and transoral laser microsurgery for identifying primary tumors in cancer of unknown primary (CUP). This work is groundbreaking because it directly addresses a major clinical dilemma: by enabling more precise identification of occult primary tumors, her research promises to reduce the volume of mucosal irradiation, thereby lowering treatment-related morbidity for head and neck cancer patients. With a growing citation footprint, Dr. Lequesne is shaping the future of minimally invasive, patient-tailored oncologic surgery.